Modeling the cost-effectiveness of maternal acellular pertussis immunization (aP) in different socioeconomic settings: A dynamic transmission model of pertussis in three Brazilian states

被引:5
作者
Luz, Paula M. [1 ]
Struchiner, Claudio J. [2 ]
Kim, Sun-Young [4 ]
Minamisava, Ruth [5 ]
Andrade, Ana Lucia S. [3 ]
Sanderson, Colin [6 ]
Russell, Louise B. [7 ]
Toscano, Cristiana M. [3 ]
机构
[1] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Ave Brasil 4365, BR-22461 Rio De Janeiro, Brazil
[2] Fundacao Getulio Vargas, Escola Matemat Aplicada, Praia Botafogo 190, Rio De Janeiro, Brazil
[3] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil
[4] Seoul Natl Univ, SNU Grad Sch Publ Hlth, Dept Healthcare Management & Policy, 1 Gwanak Ro, Seoul 08826, South Korea
[5] Univ Fed Goias, Fac Enfermagem, Goiania, Go, Brazil
[6] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, 15-17 Tavistock Pl, London WC1H 9SH, England
[7] Univ Penn, Dept Med Eth & Hlth Policy, 423 Guardian Dr, Philadelphia, PA 19104 USA
基金
比尔及梅琳达.盖茨基金会;
关键词
Pertussis; Maternal immunization; Dynamic transmission models; Cost-effectiveness analysis; VACCINATION COVERAGE; GLOBAL BURDEN; EPIDEMIOLOGY; IMMUNITY; DISEASE; RESURGENCE; DEATHS; IMPACT; COUGH;
D O I
10.1016/j.vaccine.2020.09.008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: Using dynamic transmission models we evaluated the health and cost outcomes of adding acellular pertussis (aP) vaccination of pregnant women to infant vaccination in three Brazilian states that represent different socioeconomic conditions. The primary objective was to determine whether the same model structure could be used to represent pertussis disease dynamics in differing socioeconomic conditions. Methods: We tested three model structures (SIR, SIRS, SIRSIs) to represent population-level transmission in three socio-demographically distinct Brazilian states: Sao Paulo, Parana and Bahia. Two strategies were evaluated: infant wP vaccination alone versus maternal aP immunization plus infant wP vaccination. Model projections for 2014-2029 include outpatient and inpatient pertussis cases, pertussis deaths, years of life lost, disability-adjusted life-years (DALYs) lost, and costs (in 2014 USD) of maternal aP vaccination, infant vaccination, and pertussis medical treatment. Incremental cost per DALY averted is presented from the perspective of the Brazilian National Health System. Results: Based on goodness-of-fit statistics, the SIRSIs model fit best, although it had only a modest improvement in statistical quantitative assessments relative to the SIRS model. For all three Brazilian states, maternal aP immunization led to higher costs but also saved infant lives and averted DALYs. The 2014 USD cost/DALY averted was $3068 in Sao Paulo, $2962 in Parana, and $2022 in Bahia. These results were robust in sensitivity analyses with the incremental cost-effectiveness ratios exceeding per capita gross regional product only when the probability that a pertussis case is reported was assumed higher than base case implying more overt cases and deaths and therefore more medical costs. Conclusions: The same model structure fit all three states best, supporting the idea that the disease behaves similarly across different socioeconomic conditions. We also found that immunization of pregnant women with aP is cost-effective in diverse Brazilian states. (C) 2020 The Author(s). Published by Elsevier Ltd.
引用
收藏
页码:125 / 136
页数:12
相关论文
共 10 条
  • [1] Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil
    Christovam Sartori, Ana Marli
    de Soarez, Patricia Coelho
    Fernandes, Eder Gatti
    Figueiredo Gryninger, Ligia Castellon
    Kodaira Viscondi, Juliana Yukari
    Dutilh Novaes, Hillegonda Maria
    VACCINE, 2016, 34 (13) : 1531 - 1539
  • [2] Cost-effectiveness of maternal pertussis immunization: Implications of a dynamic transmission model for low- and middle-income countries
    Kim, Sun-Young
    Min, Kyung-Duk
    Jung, Sung-Mok
    Russell, Louise B.
    Toscano, Cristiana
    Minamisava, Ruth
    Andrade, Ana Lucia S.
    Sanderson, Colin
    Sinha, Anushua
    VACCINE, 2021, 39 (01) : 147 - 157
  • [3] Tetanus, diphtheria and acellular pertussis (Tdap) vaccine for prevention of pertussis among adults aged 19 years and older in the United States: A cost-effectiveness analysis
    Cho, Bo-Hyun
    Acosta, Anna M.
    Leidner, Andrew J.
    Faulkner, Amanda E.
    Zhou, Fangjun
    PREVENTIVE MEDICINE, 2020, 134
  • [4] Impact and cost-effectiveness of a second tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine dose to prevent pertussis in the United States
    Kamiya, Hajime
    Cho, Bo-Hyun
    Messonnier, Mark L.
    Clark, Thomas A.
    Liang, Jennifer L.
    VACCINE, 2016, 34 (15) : 1832 - 1838
  • [5] Evaluating the cost-effectiveness of maternal pertussis immunization in low- and middle-income countries: A review of lessons learnt
    Russell, Louise B.
    Sobanjo-ter Meulen, Ajoke
    Toscano, Cristiana M.
    VACCINE, 2021, 39 (01) : 121 - 124
  • [6] Effectiveness of maternal immunisation with a three-component acellular pertussis vaccine at preventing pertussis in infants in the United States: Post-hoc analysis of a case-control study using Bayesian dynamic borrowing
    Cheuvart, Brigitte
    Callegaro, Andrea
    Rosillon, Dominique
    Meyer, Nadia
    Guignard, Adrienne
    VACCINE, 2023, 41 (40) : 5805 - 5812
  • [7] Cost-effectiveness analysis of universal adult immunization with tetanus-diphtheria-acellular pertussis vaccine (Tdap) versus current practice in Brazil
    Fernandes, Eder Gatti
    Christovam Sartori, Ana Marli
    de Soarez, Patricia Coelho
    Amaku, Marcos
    de Azevedo Neto, Raymundo Soares
    Dutilh Novaes, Hillegonda Maria
    VACCINE, 2020, 38 (01) : 46 - 53
  • [8] Cost-effectiveness of routine catch-up hepatitis a vaccination in the United States: Dynamic transmission modeling study
    Elbasha, Elamin H.
    Choi, Yoonyoung
    Daniels, Vince
    Goveia, Michelle G.
    VACCINE, 2021, 39 (42) : 6315 - 6321
  • [9] Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach
    Brogan, Anita J.
    Talbird, Sandra E.
    Davis, Ashley E.
    Thommes, Edward W.
    Meier, Genevieve
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (03) : 533 - 542
  • [10] Public Health Impact and Cost-Effectiveness of Hepatitis A Vaccination in the United States: A Disease Transmission Dynamic Modeling Approach
    Dhankhar, Praveen
    Nwankwo, Chizoba
    Pillsbury, Matthew
    Lauschke, Andreas
    Goveia, Michelle G.
    Acosta, Camilo J.
    Elbasha, Elamin H.
    VALUE IN HEALTH, 2015, 18 (04) : 358 - 367